A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

NCT07508787 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplant Failure and Rejection

Interventions

DRUG: Siplizumab
DRUG: Rabbit anti-thymocyte globulin

Sponsor

Nefro Avillion Clinical Development, LLC